Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NDA application submitted for Orphan Medical's Busulfex injection

Aug. 28, 1998

Novel antitumor antibiotics isolated from Streptomyces by Japanese researchers

Aug. 28, 1998

New compounds for reversing MDR reported by Nikken Chemicals

Aug. 27, 1998

Bavarian Nordic becomes first in Europe to conduct clinical trials of cancer gene therapy

Aug. 27, 1998

NDA application for Temodal submitted to the FDA

Aug. 27, 1998

Pacific Pharmaceuticals and NCI to collaborate in clinical studies of chemosensitizing agent

Aug. 27, 1998

Aphton patents its vaccine-like technology based on the neutralization of gastrin

Aug. 26, 1998

International team identifies compounds for treating slow-growing tumors

Aug. 26, 1998

Onconase inhibits cancer cell growth and contributes to apoptosis

Aug. 25, 1998

More asiatic acid derivatives in development at Dong Kook

Aug. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...